Oorsprong van het eerstegraads netwerk van Stephan Jenn
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
NovAliX SAS
 NovAliX SAS BiotechnologyHealth Technology NovAliX SAS operates as a drug discovery-focused contract research organization. It offers drug discovery services in the fields of chemistry, collaborative models, biophysics and biology. The company was founded by Stephan Jenn and Jean-Paul Renaud in 2002 and is headquartered in Illkirch, France.
2
| Holding Company | Biotechnology | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Stephan Jenn via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Urania Therapeutics SAS
 Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Biotechnology | Director/Board Member Founder |
Statistieken
Internationaal
| Frankrijk | 2 |
Sectoraal
| Health Technology | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Denis Zeyer | 2 |
| Jean-Paul Renaud | 2 |
- Beurs
- Insiders
- Stephan Jenn
- Bedrijfsconnecties
